These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 29968408

  • 1. Viral infections directly involved in kidney allograft function.
    Masutani K.
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():31-37. PubMed ID: 29968408
    [Abstract] [Full Text] [Related]

  • 2. Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients.
    Lee HM, Jang IA, Lee D, Kang EJ, Choi BS, Park CW, Choi YJ, Yang CW, Kim YS, Chung BH.
    Korean J Intern Med; 2015 Nov; 30(6):865-72. PubMed ID: 26552462
    [Abstract] [Full Text] [Related]

  • 3. BK Virus in Kidney Transplant: Current Concepts, Recent Advances, and Future Directions.
    Sharma R, Tzetzo S, Patel S, Zachariah M, Sharma S, Melendy T.
    Exp Clin Transplant; 2016 Aug; 14(4):377-84. PubMed ID: 27267780
    [Abstract] [Full Text] [Related]

  • 4. Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy.
    Kaul A, Kumar S, Bhaduaria D, Agrawal V, Sharma RK, Prasad N, Gupta A, Kumar R.
    Saudi J Kidney Dis Transpl; 2018 Aug; 29(1):101-106. PubMed ID: 29456214
    [Abstract] [Full Text] [Related]

  • 5. Differential Diagnosis of Interstitial Allograft Rejection and BKV Nephropathy by T-cell Receptor Sequencing.
    Stervbo U, Nienen M, Hecht J, Viebahn R, Amann K, Westhoff TH, Babel N.
    Transplantation; 2020 Apr; 104(4):e107-e108. PubMed ID: 32224816
    [No Abstract] [Full Text] [Related]

  • 6. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
    Halim MA, Al-Otaibi T, Gheith O, Mosaad A, Zakaria Z, Said T, Nair P, Nampoory NM.
    Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
    [Abstract] [Full Text] [Related]

  • 7. Temporal serum creatinine increase and exacerbation of tubulointerstitial inflammation during the first two months in resolving polyomavirus BK nephropathy.
    Masutani K, Tsuchimoto A, Matsukuma Y, Kurihara K, Nishiki T, Kitada H, Tanaka M, Kitazono T, Tsuruya K.
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():45-50. PubMed ID: 26031586
    [Abstract] [Full Text] [Related]

  • 8. Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy.
    Jaw J, Hill P, Goodman D.
    Nephrology (Carlton); 2017 Apr; 22(4):326-329. PubMed ID: 28247521
    [Abstract] [Full Text] [Related]

  • 9. Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
    Halim MA, Al-Otaibi T, Gheith O, Zkaria Z, Mosaad A, Said T, Nair P, Nampoory N.
    Exp Clin Transplant; 2014 Dec; 12(6):528-33. PubMed ID: 25489803
    [Abstract] [Full Text] [Related]

  • 10. Prevalence and Risk Factors of BK Viremia and Clinical Impact of BK Virus Surveillance on Outcomes in Kidney Transplant Recipients: A Single-Center Cross-Sectional Study.
    Ji J, Feng S, Jiang Y, Wang W, Zhang X.
    Exp Clin Transplant; 2019 Dec; 17(6):727-731. PubMed ID: 30995893
    [Abstract] [Full Text] [Related]

  • 11. Management of BK virus nephropathy in kidney transplant recipients at the Royal Hospital - Clinical Audit - Oman.
    Al-Raisi F, Mohsin N, Kamble P.
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():156-8. PubMed ID: 25894146
    [Abstract] [Full Text] [Related]

  • 12. Elimination of BK viremia in renal transplant recipients by optimization of immunosuppressive medications without precipitating acute rejection.
    Jha A, Ahmed W, Pakkyara A, Shaheen F, Al Salmi I.
    Saudi J Kidney Dis Transpl; 2018 Apr; 29(5):1073-1081. PubMed ID: 30381503
    [Abstract] [Full Text] [Related]

  • 13. BK Virus nephropathy in living donor renal allograft recipients: An observational study from a large transplant center in India.
    Gupta P, Gupta A, Bhalla AK, Malik M, Gupta A, Bhargava V, Rana DS.
    Saudi J Kidney Dis Transpl; 2018 Apr; 29(6):1366-1370. PubMed ID: 30588968
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. BK Virus in Renal Transplant Patients Using Alemtuzumab for Induction Immunosuppression.
    Korneffel K, Gehring B, Rospert D, Rees M, Ortiz J.
    Exp Clin Transplant; 2020 Oct; 18(5):557-563. PubMed ID: 31324134
    [Abstract] [Full Text] [Related]

  • 16. Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation.
    Ahlenstiel-Grunow T, Pape L.
    Pediatr Nephrol; 2020 Mar; 35(3):375-382. PubMed ID: 30539254
    [Abstract] [Full Text] [Related]

  • 17. BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation.
    Ahlenstiel-Grunow T, Sester M, Sester U, Hirsch HH, Pape L.
    Transplantation; 2020 Nov; 104(11):2393-2402. PubMed ID: 31985731
    [Abstract] [Full Text] [Related]

  • 18. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients.
    Abend JR, Changala M, Sathe A, Casey F, Kistler A, Chandran S, Howard A, Wojciechowski D.
    Transplantation; 2017 Jun; 101(6):1495-1505. PubMed ID: 27854236
    [Abstract] [Full Text] [Related]

  • 19. BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients.
    Westphal SG, Lyden ER, Langewisch ED, Miles CD.
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28509373
    [Abstract] [Full Text] [Related]

  • 20. Viral Origin, Clinical Course, and Renal Outcomes in Patients With BK Virus Infection After Living-Donor Renal Transplantation.
    Schwarz A, Linnenweber-Held S, Heim A, Framke T, Haller H, Schmitt C.
    Transplantation; 2016 Apr; 100(4):844-53. PubMed ID: 26720302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.